Medication-induced lung disease in children.

Andrew H Schapiro, Kristen L Ruff, R Paul Guillerman

Abstract readReview

In one paragraph

Review in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Incidence, clinical features and risk factors of interstitial pneumonia in children with acute lymphoblastic leukemia.Annals of hematology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew H SchapiroDepartment of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. andrew.schapiro@cchmc.org.

Kristen L RuffDepartment of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.

R Paul GuillermanDepartment of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication-induced lung disease is rare in children but can be associated with considerable morbidity and mortality and can alter treatment regimens for children with a variety of conditions. Medication-induced lung disease tends to occur in association with certain categories of medication and tends to manifest as one of several patterns of lung disease on CT. We review classes of medications associated with medication-induced lung disease, clinical diagnosis and management of the condition including the role of the radiologist, and CT patterns of disease to enable the radiologist to more fully contribute to multidisciplinary diagnosis and potentially be the first to recognize and suggest the possibility of this condition.

Indexed as

Drug-Related Side Effects and Adverse ReactionsLung DiseasesTomography, X-Ray ComputedChildChild, PreschoolHumansChildrenComputed tomographyDrug-inducedLung diseaseMedication-induced

Identifiers

PMID41288669

DOI10.1007/s00247-025-06420-1

PMCPMC12881037

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.